None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed with type-II diabetes in the age group of 30-70 years. 2. Taking standard medication advised by the physician for the past three months. 3. Subjects whose fasting blood glucose levels are maintained in the range of 100 and 120 mg/dl and normal in other clinical and laboratory parameters. 4. Individual as well as family history of diabetes and obesity. 5. Willing to give written informed consent.
Exclusion criteria
Exclusion criteria: Diabetic patients currently under treatment for heart disease, cancer, post-surgery patients, tuberculosis and other chronic diseases. 2. Subjects who are bedridden for chronic diseases for prolonged time and kidney diseases and whose serum creatinine levels are >1.5 mg/dl 3. Chronic chewers of tobacco and usage of drugs which exerts intoxication. 4. Pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| glucose. 2. To monitor the effect of dose escalation on glycemic level. Timepoint: | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid profile,BMITimepoint: 3 MONTHS | — |
Countries
India